Arcellx (ACLX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

ACLX Stock Forecast

Arcellx stock forecast is as follows: an average price target of $111.60 (represents a 47.74% upside from ACLX’s last price of $75.54) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.

ACLX Price Target

The average price target for Arcellx (ACLX) is $111.60 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $122.00 to $95.00. This represents a potential 47.74% upside from ACLX's last price of $75.54.

ACLX Analyst Ratings

Buy

According to 12 Wall Street analysts, Arcellx's rating consensus is 'Buy'. The analyst rating breakdown for ACLX stock is 0 'Strong Buy' (0.00%), 12 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Arcellx Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 08, 2024	Biren Amin	Piper Sandler	$115.00	$101.09	13.76%	52.24%
Nov 06, 2024	Jack Allen	Robert W. Baird	$106.00	$86.08	23.13%	40.32%
Nov 06, 2024	Emily Bodnar	H.C. Wainwright	$95.00	$86.08	10.36%	25.76%
Oct 29, 2024	Cory Kasimov	Evercore ISI	$120.00	$84.99	41.19%	58.86%
Oct 18, 2024	Ben Burnett	Stifel Nicolaus	$122.00	$95.27	28.06%	61.50%
May 31, 2024	Biren Amin	Piper Sandler	$70.00	$52.24	34.00%	-7.33%
May 15, 2024	Benjamin Burnett	Stifel Nicolaus	$83.00	$50.62	63.97%	9.88%
May 13, 2024	Cory Kasimov	Evercore ISI	$85.00	$49.77	70.79%	12.52%
Mar 18, 2024	Gil Blum	Needham	$81.00	$69.11	17.20%	7.23%
Dec 12, 2022		Needham	$35.00	$28.84	21.34%	-53.67%
Dec 12, 2022		Barclays	$38.00	$28.02	35.62%	-49.70%
Jul 20, 2022	John Newman	Canaccord Genuity	$32.00	$18.27	75.15%	-57.64%
Jun 23, 2022		Leerink Partners	$38.00	$15.65	142.81%	-49.70%

The latest Arcellx stock forecast, released on Nov 08, 2024 by Biren Amin from Piper Sandler, set a price target of $115.00, which represents a 13.76% increase from the stock price at the time of the forecast ($101.09), and a 52.24% increase from ACLX last price ($75.54).

Arcellx Price Target by Period

	1M	3M	12M
# Anlaysts	-	5	9
Avg Price Target	-	$111.60	$97.44
Last Closing Price	$75.54	$75.54	$75.54
Upside/Downside	-100.00%	47.74%	28.99%

In the current month, the average price target of Arcellx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Arcellx's last price of $75.54. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Dec 09, 2024	Benchmark	Positive	Positive	Hold
Dec 09, 2024	Bank of America Securities	Buy	Buy	Hold
Nov 08, 2024	Piper Sandler	Overweight	Overweight	Hold
Nov 06, 2024	Citigroup	Buy	Buy	Hold
Nov 06, 2024	H.C. Wainwright	Buy	Buy	Hold
Nov 05, 2024	Bank of America Securities	Buy	Buy	Hold
Oct 29, 2024	Evercore ISI	Outperform	Outperform	Hold
Oct 18, 2024	Needham	Buy	Buy	Hold
Sep 03, 2024	Cantor Fitzgerald		Overweight	Initialise
Jul 22, 2024	Piper Sandler	Buy	Buy	Hold
Jul 22, 2024	Needham	Underperform	Underperform	Hold
Jun 18, 2024	Needham	Underperform	Underperform	Hold
Jun 18, 2024	Piper Sandler	Buy	Buy	Hold
May 31, 2024	Stifel Nicolaus	Buy	Buy	Hold
May 31, 2024	Piper Sandler		Overweight	Initialise
May 14, 2024	Needham	Buy	Buy	Hold
May 13, 2024	Evercore ISI		Outperform	Initialise
Mar 07, 2024	Morgan Stanley		Overweight	Initialise
Jan 04, 2024	Needham	Buy	Buy	Hold
Aug 15, 2023	Needham	Hold	Hold	Hold
Dec 12, 2022	Needham	Buy	Buy	Hold
Dec 12, 2022	Barclays	Overweight	Overweight	Hold
Oct 27, 2022	Needham		Buy	Initialise
Jun 23, 2022	SVB Leerink	Outperform	Outperform	Hold
May 13, 2022	SVB Leerink	Outperform	Outperform	Hold

Arcellx's last stock rating was published by Benchmark on Dec 09, 2024. The company gave ACLX a "Positive" rating, the same as its previous rate.

Arcellx Financial Forecast

Arcellx Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$63.15M	$14.96M	$14.30M	$17.91M	-
Avg Forecast	$100.60M	$85.80M	$26.03M	$26.03M	$35.19M	$23.98M	$20.91M	$21.21M	$25.71M	$38.73M	$22.04M	$20.67M	$20.07M	$17.49M	$39.29M	$100.97M	$3.00M
High Forecast	$139.73M	$119.17M	$36.15M	$36.15M	$48.87M	$33.31M	$29.04M	$24.67M	$36.29M	$38.87M	$22.04M	$20.67M	$25.12M	$17.92M	$54.57M	$140.25M	$4.17M
Low Forecast	$73.20M	$62.43M	$18.94M	$18.94M	$25.60M	$17.45M	$15.21M	$17.70M	$16.88M	$38.59M	$22.04M	$20.67M	$15.07M	$17.07M	$28.59M	$73.47M	$2.18M
# Analysts	4	4	4	4	3	3	3	5	10	9	3	4	7	5	6	3	2
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	3.15%	0.86%	0.36%	0.18%	-

Arcellx's average Quarter revenue forecast for Mar 24 based on 4 analysts is $20.67M, with a low forecast of $20.67M, and a high forecast of $20.67M. ACLX's average Quarter revenue forecast represents a -67.27% decrease compared to the company's last Quarter revenue of $63.15M (Dec 23).

Arcellx EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
# Analysts	4	4	4	4	3	3	3	5	10	9	3	4	7	5	6	3	2
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$35.76M	$-44.86M	$-29.56M	$-25.56M	$-35.29M
Avg Forecast	$68.78M	$58.66M	$17.80M	$17.80M	$24.06M	$16.40M	$14.30M	$14.50M	$17.58M	$26.48M	$15.07M	$14.13M	$13.72M	$11.96M	$26.86M	$69.04M	$2.05M
High Forecast	$95.53M	$81.48M	$24.72M	$24.72M	$33.42M	$22.78M	$19.86M	$16.87M	$24.81M	$26.57M	$15.07M	$14.13M	$17.18M	$12.25M	$37.31M	$95.89M	$2.85M
Low Forecast	$50.05M	$42.68M	$12.95M	$12.95M	$17.50M	$11.93M	$10.40M	$12.11M	$11.54M	$26.38M	$15.07M	$14.13M	$10.31M	$11.67M	$19.55M	$50.23M	$1.49M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	2.61%	-3.75%	-1.10%	-0.37%	-17.20%

4 analysts predict ACLX's average Quarter EBITDA for Mar 24 to be $14.13M, with a high of $14.13M and a low of $14.13M. This is -60.49% lower than Arcellx's previous annual EBITDA (Dec 23) of $35.76M.

Arcellx Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
# Analysts	4	4	4	4	3	3	3	5	10	9	3	4	7	5	6	3	2
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$19.52M	$-39.34M	$-23.85M	$-27.34M	$-37.41M
Avg Forecast	$-38.79M	$-43.67M	$-53.82M	$-50.36M	$-25.63M	$-42.27M	$-40.70M	$-37.45M	$-29.96M	$-16.67M	$-27.93M	$-27.33M	$-28.66M	$-29.58M	$-39.55M	$98.06M	$-52.50M
High Forecast	$-25.06M	$-28.21M	$-34.76M	$-32.52M	$-16.56M	$-27.30M	$-26.29M	$-27.59M	$-565.26K	$-10.77M	$-18.04M	$-17.65M	$-14.56M	$-19.10M	$-25.54M	$147.64M	$-33.91M
Low Forecast	$-58.41M	$-65.75M	$-81.03M	$-75.82M	$-38.59M	$-63.64M	$-61.27M	$-44.84M	$-49.74M	$-25.09M	$-42.04M	$-41.15M	$-50.05M	$-44.53M	$-59.54M	$63.34M	$-79.05M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-0.68%	1.33%	0.60%	-0.28%	0.71%

Arcellx's average Quarter net income forecast for Mar 24 is $-27.33M, with a range of $-41.15M to $-17.65M. ACLX's average Quarter net income forecast represents a -240.04% decrease compared to the company's last Quarter net income of $19.52M (Dec 23).

Arcellx SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
# Analysts	4	4	4	4	3	3	3	5	10	9	3	4	7	5	6	3	2
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$19.37M	$16.01M	$15.54M	$15.44M	$14.06M
Avg Forecast	$92.58M	$78.96M	$23.96M	$23.96M	$32.38M	$22.07M	$19.24M	$19.52M	$23.66M	$35.64M	$20.28M	$19.02M	$18.47M	$16.10M	$36.16M	$92.92M	$2.76M
High Forecast	$128.59M	$109.67M	$33.27M	$33.27M	$44.98M	$30.66M	$26.73M	$22.70M	$33.40M	$35.77M	$20.28M	$19.02M	$23.12M	$16.49M	$50.22M	$129.07M	$3.83M
Low Forecast	$67.36M	$57.45M	$17.43M	$17.43M	$23.56M	$16.06M	$14.00M	$16.29M	$15.53M	$35.51M	$20.28M	$19.02M	$13.87M	$15.71M	$26.31M	$67.61M	$2.01M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.05%	0.99%	0.43%	0.17%	5.09%

Arcellx's average Quarter SG&A projection for Mar 24 is $19.02M, based on 4 Wall Street analysts, with a range of $19.02M to $19.02M. The forecast indicates a -1.80% fall compared to ACLX last annual SG&A of $19.37M (Dec 23).

Arcellx EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
# Analysts	4	4	4	4	3	3	3	5	10	9	3	4	7	5	6	3	2
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.00	$-0.00	$-0.58	$-1.03
Avg Forecast	$-0.72	$-0.81	$-1.00	$-0.94	$-0.48	$-0.79	$-0.76	$-0.70	$-0.56	$-0.31	$-0.52	$-0.51	$-0.53	$-0.55	$-0.73	$1.82	$-0.98
High Forecast	$-0.47	$-0.52	$-0.65	$-0.60	$-0.31	$-0.51	$-0.49	$-0.51	$-0.01	$-0.20	$-0.34	$-0.33	$-0.27	$-0.35	$-0.47	$2.74	$-0.63
Low Forecast	$-1.09	$-1.22	$-1.51	$-1.41	$-0.72	$-1.18	$-1.14	$-0.83	$-0.92	$-0.47	$-0.78	$-0.76	$-0.93	$-0.83	$-1.11	$1.18	$-1.47
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-0.00%	0.00%	0.00%	-0.32%	1.06%

According to 4 Wall Street analysts, Arcellx's projected average Quarter EPS for Mar 24 is $-0.51, with a low estimate of $-0.76 and a high estimate of $-0.33. This represents a -127045.00% decrease compared to ACLX previous annual EPS of - (Dec 23).

Arcellx Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
VTYX	Ventyx Biosciences	$2.37	$33.86	1328.69%	Buy
BMEA	Biomea Fusion	$4.64	$23.33	402.80%	Buy
AMLX	Amylyx Pharmaceuticals	$4.28	$8.25	92.76%	Buy
DAWN	Day One Biopharmaceuticals	$12.64	$24.00	89.87%	Buy
ACLX	Arcellx	$82.03	$111.60	36.05%	Buy
NUVL	Nuvalent	$88.10	$114.80	30.31%	Buy

ACLX Forecast FAQ

Is Arcellx a good buy?

Yes, according to 12 Wall Street analysts, Arcellx (ACLX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 12 'Buy' recommendations, accounting for 100.00% of ACLX's total ratings.

What is ACLX's price target?

Arcellx (ACLX) average price target is $111.6 with a range of $95 to $122, implying a 47.74% from its last price of $75.54. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Arcellx stock go up soon?

According to Wall Street analysts' prediction for ACLX stock, the company can go up by 47.74% (from the last price of $75.54 to the average price target of $111.6), up by 61.50% based on the highest stock price target, and up by 25.76% based on the lowest stock price target.

Can Arcellx stock reach $110?

ACLX's average twelve months analyst stock price target of $111.6 supports the claim that Arcellx can reach $110 in the near future.

What are Arcellx's analysts' financial forecasts?

Arcellx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $101.29M (high $135.9M, low $75.97M), average EBITDA is $69.25M (high $92.91M, low $51.94M), average net income is $-146M (high $-97.734M, low $-208M), average SG&A $93.22M (high $125.06M, low $69.92M), and average EPS is $-2.713 (high $-1.816, low $-3.871). ACLX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $238.46M (high $331.2M, low $173.51M), average EBITDA is $163.04M (high $226.45M, low $118.63M), average net income is $-187M (high $-121M, low $-281M), average SG&A $219.45M (high $304.8M, low $159.67M), and average EPS is $-3.468 (high $-2.24, low $-5.221).

Did the ACLX's actual financial results beat the analysts' financial forecasts?

Based on Arcellx's last annual report (Dec 2023), the company's revenue was $110.32M, which missed the average analysts forecast of $177.82M by -37.96%. Apple's EBITDA was $-89.88M, missing the average prediction of $121.58M by -173.93%. The company's net income was $-70.69M, missing the average estimation of $276.64K by -25652.60%. Apple's SG&A was $66.35M, missing the average forecast of $163.65M by -59.46%. Lastly, the company's EPS was $-0.0015, missing the average prediction of $0.00514 by -129.18%. In terms of the last quarterly report (Dec 2023), Arcellx's revenue was $63.15M, beating the average analysts' forecast of $20.07M by 214.71%. The company's EBITDA was $35.76M, beating the average prediction of $13.72M by 160.67%. Arcellx's net income was $19.52M, missing the average estimation of $-28.663M by -168.08%. The company's SG&A was $19.37M, beating the average forecast of $18.47M by 4.87%. Lastly, the company's EPS was $0.0004, missing the average prediction of $-0.533 by -100.08%